Orange Book product · Brand (NDA)

ZIOPTAN

TAFLUPROST

Brand (NDA)NDA 202514TE ATRX THEA PHARMA

Feb 10, 2012

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Feb 10, 2012
14 yr 7 mo ago
Today
Patent 10864159 expires
Listed drug product patent expiration.
May 28, 2029
in 3 yr
Patent 9999593 expires
Listed drug product patent expiration.
May 28, 2029
in 3 yr

Active ingredient

TAFLUPROST

Strength

0.0015%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Application

NDA 202514

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
10864159	May 28, 2029	in 3 yr	ProductU-778
9999593	May 28, 2029	in 3 yr	Product